
AVTX
Avalo Therapeutics Inc.
$15.92
$0.00(0.00%)
43
Overall
60
Value
33
Tech
36
Quality
Market Cap
$281.44M
Volume
557.68K
52W Range
$3.39 - $20.72
Target Price
$37.89
Company Overview
| Mkt Cap | $281.44M | Price | $15.92 |
| Volume | 557.68K | Change | +0.00% |
| P/E Ratio | -8.0 | Open | $16.15 |
| Revenue | $441.0K | Prev Close | $15.92 |
| Net Income | $-35.1M | 52W Range | $3.39 - $20.72 |
| Div Yield | N/A | Target | $37.89 |
| Overall | 43 | Value | 60 |
| Quality | 36 | Technical | 33 |
No chart data available
Latest News
Kepler Capital Sticks to Their Hold Rating for Avantium N.V. (0RNP)
TipRanks Auto-Generated Intelligence Newsdesk•17 days ago
Avalo Therapeutics (AVTX) Receives a Buy from Stifel Nicolaus
TipRanks Auto-Generated Intelligence Newsdesk•20 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $15.92 | 0% | 557.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |